NCT06186843

Brief Summary

The goal of this clinical trial is to evaluate cardiometabolic and inflammatory parameters in kidney transplant recipients after transitioning to a plant-based diet (PBD). The main aims of the study are as follows:

  • To test the feasibility of transiting renal allograft recipients who are \> 3 months post-transplant to a PBD
  • To study the effect of a PBD on cardiometabolic parameters in kidney transplant recipients
  • To assess the effect of a PBD on peripheral blood Th17/Treg ratio and systemic inflammation in kidney transplant recipients Participants will be asked to:
  • Complete a 2-week investigator-designed PBD transition program
  • Follow a PBD for a minimum of 16 weeks
  • Consent for blood draws, urine samples, and fecal samples along with physical exams
  • Complete intermittent food frequency questionnaires and quality of life questionnaires
  • Periodically meet with investigators and other study participants Researchers will compare baseline measurements with future measurements for each participant.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Feb 2024Jun 2026

First Submitted

Initial submission to the registry

October 18, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 2, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 29, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

2.1 years

First QC Date

October 18, 2023

Last Update Submit

August 29, 2025

Conditions

Keywords

Kidney transplantLifestyle changePlant-based dietMetabolic syndromeDiabetesHypertensionKidney functionInflammatory states

Outcome Measures

Primary Outcomes (12)

  • Th17/ Treg ratio

    Th17/Treg cell ratio in peripheral blood. Results expressed as cell frequencies

    Baseline, week 10, 18, 26

  • hsCRP

    Plasma levels measured using enzyme-linked immunosorbent assay (ELISA) expressed as units/ mL

    Baseline, week 10, 18, 26

  • Interleukin (IL) Levels (IL-6, IL-17, IL-21)

    Plasma levels measured using ELISA expressed as units/ mL

    Baseline, week 10, 18, 26

  • Weight

    Kilograms

    Baseline, week 10, 18, 26

  • BMI

    Weight in kilograms (kg) and height (m) in meters will be combined to report BMI kg/m\^2

    Baseline, week 10, 18, 26

  • Anthropometry

    Mid arm and abdominal circumference will be measured in centimeters

    Baseline, week 18, 26

  • Blood pressure

    Systolic blood pressure (mmHg)/ Diastolic blood pressure (mmHg)

    Baseline, week 10, 18, 26

  • HbA1c

    mmol/mol and percent (percent of total hemoglobin)

    Baseline, week 10, 18, 26

  • Non-fasting blood glucose

    mg/dL

    Baseline, week 10, 18, 26

  • Total cholesterol

    mg/dL

    Baseline, week 10, 18, 26

  • Food frequency questionnaire

    Nutrient intake and physical activity levels will be calculated

    Baseline, week 18, 26

  • Weekly one day food recall

    Dietary compliance will be measured with weekly one day food recall. The percentage of total daily food that is whole food plant-based will be calculated

    Once per week at baseline and weeks 3-18

Secondary Outcomes (7)

  • Estimated glomerular filtration rate

    Baseline, week 10, 18, 26

  • Creatinine

    Baseline, week 10, 18, 26

  • Kidney disease and quality of life (KDQOL-36)

    Baseline, week 18, 26

  • Changes in gut microbiome

    Baseline, week 18, 26

  • Low-density lipoprotein (LDL) cholesterol

    Baseline, week 10, 18, 26

  • +2 more secondary outcomes

Other Outcomes (4)

  • Blood electrolytes (Na, K, Cl, Ca, Phosphorous)

    Baseline, week 10, 18, 26

  • Urine protein

    Baseline, week 10, 18, 26

  • Urine albumin

    Baseline, week 10, 18, 26

  • +1 more other outcomes

Study Arms (1)

Plant-based diet

EXPERIMENTAL

The group will follow a plant-based diet. Compliance will be checked with dietary questionnaires.

Behavioral: Plant-based diet

Interventions

A two week training program will be completed which consists of information, resources and activities that will help participants transition to a plant-based diet. Each day of the program, participants will engage with material that provides information about how a plant-based diet can improve health outcomes, how to cook plant-based meals, what to shop for when eating plant-based, and other information that will help participants become comfortable with this dietary change. In addition, each participant will have a virtual, weekly check-in with one of the investigators. Finally, participants will be encouraged to attend a once monthly group session with all participants.

Plant-based diet

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 3 months post-kidney transplant
  • On style immunosuppressive medication
  • Without evidence of active infection/ inflammatory conditions
  • Estimated glomerular filtration rate \> 45ml/min/1.73 m\^2
  • English speaking
  • Reliable internet access

You may not qualify if:

  • Acute/ chronic allograft rejection
  • History of non-compliance
  • Advance heart failure
  • Liver disease
  • Pregnancy
  • Malignancy
  • Chronic Infection
  • Currently following a plant-based diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Transplant Institute

Washington D.C., District of Columbia, 20037, United States

Location

Related Publications (18)

  • Jezior D, Krajewska M, Madziarska K, Kurc-Darak B, Janczak D, Patrzalek D, Boryslawski K, Klinger M. Posttransplant overweight and obesity: myth or reality? Transplant Proc. 2007 Nov;39(9):2772-5. doi: 10.1016/j.transproceed.2007.09.001.

    PMID: 18021984BACKGROUND
  • Malgorzewicz S, Woloszyk P, Chamienia A, Jankowska M, Debska-Slizien A. Obesity Risk Factors in Patients After Kidney Transplantation. Transplant Proc. 2018 Jul-Aug;50(6):1786-1789. doi: 10.1016/j.transproceed.2018.02.099. Epub 2018 Mar 13.

    PMID: 29937291BACKGROUND
  • Shah B, Newman JD, Woolf K, Ganguzza L, Guo Y, Allen N, Zhong J, Fisher EA, Slater J. Anti-Inflammatory Effects of a Vegan Diet Versus the American Heart Association-Recommended Diet in Coronary Artery Disease Trial. J Am Heart Assoc. 2018 Dec 4;7(23):e011367. doi: 10.1161/JAHA.118.011367.

    PMID: 30571591BACKGROUND
  • Tan TG, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, Pasman L, Ortiz-Lopez A, Jupp R, Wu HJ, Kasper DL, Benoist C, Mathis D. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150. doi: 10.1073/pnas.1617460113. Epub 2016 Nov 23.

    PMID: 27911839BACKGROUND
  • Raj DS, Sohn MB, Charytan DM, Himmelfarb J, Ikizler TA, Mehrotra R, Ramezani A, Regunathan-Shenk R, Hsu JY, Landis JR, Li H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study. Kidney360. 2021 Jan 15;2(3):445-455. doi: 10.34067/KID.0006132020. eCollection 2021 Mar 25.

    PMID: 35369018BACKGROUND
  • Serrano M, Srivastava A, Buck G, Zhu B, Edupuganti L, Adegbulugbe E, Shankaranarayanan D, Kopp JB, Raj DS. Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice. Am J Nephrol. 2022;53(8-9):646-651. doi: 10.1159/000526957. Epub 2022 Nov 7.

    PMID: 36349783BACKGROUND
  • Hoogeveen EK, Aalten J, Rothman KJ, Roodnat JI, Mallat MJ, Borm G, Weimar W, Hoitsma AJ, de Fijter JW. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation. 2011 Apr 27;91(8):869-74. doi: 10.1097/TP.0b013e3182100f3a.

    PMID: 21326138BACKGROUND
  • Hill CJ, Courtney AE, Cardwell CR, Maxwell AP, Lucarelli G, Veroux M, Furriel F, Cannon RM, Hoogeveen EK, Doshi M, McCaughan JA. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015 Aug;30(8):1403-11. doi: 10.1093/ndt/gfv214. Epub 2015 Jun 4.

    PMID: 26044837BACKGROUND
  • Nicoletto BB, Fonseca NK, Manfro RC, Goncalves LF, Leitao CB, Souza GC. Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis. Transplantation. 2014 Jul 27;98(2):167-76. doi: 10.1097/TP.0000000000000028.

    PMID: 24911038BACKGROUND
  • Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A, Guzman NN, Reilly M, Wolman M, Rosas SE, Cuevas M, Fischer M, Lustigova E, Master SR, Xie D, Appleby D, Joffe M, Kusek J, Feldman HI, Raj DS; Chronic Renal Insufficiency Cohort (CRIC) Study. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). 2014 May;22(5):1359-66. doi: 10.1002/oby.20692. Epub 2014 Feb 11.

    PMID: 24415732BACKGROUND
  • Abedini S, Holme I, Marz W, Weihrauch G, Fellstrom B, Jardine A, Cole E, Maes B, Neumayer HH, Gronhagen-Riska C, Ambuhl P, Holdaas H; ALERT study group. Inflammation in renal transplantation. Clin J Am Soc Nephrol. 2009 Jul;4(7):1246-54. doi: 10.2215/CJN.00930209. Epub 2009 Jun 18.

    PMID: 19541816BACKGROUND
  • Nettleton JA, Steffen LM, Palmas W, Burke GL, Jacobs DR Jr. Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis. Am J Clin Nutr. 2008 Jun;87(6):1825-36. doi: 10.1093/ajcn/87.6.1825.

    PMID: 18541574BACKGROUND
  • Gutierrez OM, Muntner P, Rizk DV, McClellan WM, Warnock DG, Newby PK, Judd SE. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study. Am J Kidney Dis. 2014 Aug;64(2):204-13. doi: 10.1053/j.ajkd.2014.02.013. Epub 2014 Mar 27.

    PMID: 24679894BACKGROUND
  • Cyrino LG, Galpern J, Moore L, Borgi L, Riella LV. A Narrative Review of Dietary Approaches for Kidney Transplant Patients. Kidney Int Rep. 2021 Apr 27;6(7):1764-1774. doi: 10.1016/j.ekir.2021.04.009. eCollection 2021 Jul.

    PMID: 34307973BACKGROUND
  • Gao B, Alonzo-Palma N, Brooks B, Jose A, Barupal D, Jagadeesan M, Nobakht E, Collins A, Ramezani A, Omar B, Amdur RL, Raj DS. A Pilot Study on the Effect of Prebiotic on Host-Microbial Co-metabolism in Peritoneal Dialysis Patients. Kidney Int Rep. 2020 Jun 1;5(8):1309-1315. doi: 10.1016/j.ekir.2020.05.023. eCollection 2020 Aug. No abstract available.

    PMID: 32775832BACKGROUND
  • Amdur RL, Paul R, Barrows ED, Kincaid D, Muralidharan J, Nobakht E, Centron-Vinales P, Siddiqi M, Patel SS, Raj DS. The potassium regulator patiromer affects serum and stool electrolytes in patients receiving hemodialysis. Kidney Int. 2020 Nov;98(5):1331-1340. doi: 10.1016/j.kint.2020.06.042. Epub 2020 Aug 1.

    PMID: 32750456BACKGROUND
  • Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr. 2002 Jan;12(1):17-31. doi: 10.1053/jren.2002.29598.

    PMID: 11823990BACKGROUND
  • Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004 Jun;27(6):1487-95. doi: 10.2337/diacare.27.6.1487.

    PMID: 15161807BACKGROUND

MeSH Terms

Conditions

Renal Insufficiency, ChronicHypertensionDiabetes MellitusMetabolic SyndromeInflammationFeeding Behavior

Interventions

Diet, Plant-Based

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesInsulin ResistanceHyperinsulinismBehavior, AnimalBehavior

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Muralidharan Jagadeesan, MD

    George Washington University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
There will be no masking.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A single group of kidney transplant recipients will transition to a plant-based diet and be followed for 24 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 18, 2023

First Posted

January 2, 2024

Study Start

February 29, 2024

Primary Completion

March 25, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

September 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

The details of the plan are still being decided.

Locations